Effects of antidepressant treatment following myocardial infarction

Key points
- Depression following myocardial infarction is associated with poor cardiac prognosis.
- Aims To evaluate the effects of antidepressant treatment compared with usual care in an effectiveness study.
- Method In a multicentre randomised controlled trial, 2177 myocardial infarction patients were evaluated for ICD–10 depression and randomised to intervention (n=209) or care as usual (n=122).
- The cardiac event rate was 14% among the intervention group and 13% among controls (OR=1.07, 95% CI 0.57–2.00).
Depression following myocardial infarction is associated with poor cardiac prognosis. It is unclear whether antidepressant treatment improves long-term depression status and cardiac prognosis.
Aims To evaluate the effects of antidepressant treatment compared with usual care in an effectiveness study.
Method In a multicentre randomised controlled trial, 2177 myocardial infarction patients were evaluated for ICD–10 depression and randomised to intervention (n=209) or care as usual (n=122). Both arms were evaluated at 18 months post-myocardial infarction for long-term depression status and new cardiac events.
Results No differences were observed between intervention and control groups in mean scores on the Beck Depression Inventory (11.0, s.d.=7.5 v.10.2, s.d.=5.1, P=0.45) or presence of ICD–10 depression (30.5 v. 32.1%, P=0.68). The cardiac event rate was 14% among the intervention group and 13% among controls (OR=1.07, 95% CI 0.57–2.00).
Conclusions: Antidepressant treatment did not alter long-term depression post-myocardial infarction status or improve cardiac prognosis [more...]
OOST P. van MELLE, MD, PhD
Department of Cardiology, Thoraxcenter, University Medical Center Groningen
PETER de JONGE, PhD
Department of Internal Medicine and Department of Psychiatry, University Medical Center Groningen
ADRIAAN HONIG, MD, PhD
Department of Psychiatry, St Lucas Andreas Hospital, Amsterdam
AART H. SCHENE, MD, PhD, ASTRID M. G. KUYPER, MD and HARRY J. G. M. CRIJNS, MD, PhD
Department of Cardiology, University Hospital Maastricht
ANNIQUE SCHINS, MD, PhD
Department of Psychiatry, University Hospital Maastricht
DORIEN TULNER, MD
Department of Psychiatry, Medical Center Leeuwarden
MAARTEN P. van den BERG, MD, PhD
Department of Cardiology, University Medical Center Groningen
JOHAN ORMEL, PhD
Department of Social Psychiatry and Psychiatric Epidemiology, University Medical Center Groningen, The Netherlands
Correspondence: Dr Peter de Jonge, Department of Internal Medicine and Department of Psychiatry, University Medical Center Groningen, P.O. Box 30.001, 9700 RB, The Netherlands. Email: [email protected]
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Mental Health →
NewsHeroin - Assisted Treatment (HAT)
Drug replacement and maintenance therapy have a long history of providing individuals struggling with problematic drug use with legal access to drugs that would otherwise be obtained through illegal means. More than a…
16 April 2015
NewsLink between social anxiety and drug use offers opportunities for more effective treatment
A team led by Case Western Reserve researchers has identified a potentially powerful approach to lowering relapse rates among the ranks of those addicted to illegal drugs or alcohol. In a study of nearly 200 teenagers…
16 April 2015
NewsExercise questioned as depression treatment
“Exercise doesn't help depression,” according to The Guardian. The paper said that patients advised to exercise fare no better than those who receive only standard care. Exercise is among the treatments for depression…





